Caption Management’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
Other funds holding ALNY
Caption Management's ALNY Position: Q3 2026 in Review
Caption Management opened a new position in Alnylam Pharmaceuticals (ALNY) in Q3 2026: 21,400 shares worth $5.28M. The stake represents 0.02% of the portfolio and ranks #644 among its holdings. This is a return to the name: Caption Management previously reported a position in ALNY as recently as Q3 2024.
Caption Management first reported a position in ALNY in Q3 2018 and has held it in 14 quarters since. The position peaked at $41.4M in Q2 2024. 661 funds tracked by Wall St. Rank hold ALNY as of Q3 2026.
- Caption Management held 21,400 shares of Alnylam Pharmaceuticals worth $5.28M as of Q3 2026.
- Alnylam Pharmaceuticals was a new Caption Management position in Q3 2026.
- Alnylam Pharmaceuticals made up 0.02% of Caption Management's portfolio in Q3 2026, its #644 holding.
- Caption Management first reported a position in Alnylam Pharmaceuticals in Q3 2018 and has held it in 14 quarters since.
- Caption Management's Alnylam Pharmaceuticals position peaked at $41.4M in Q2 2024.
- 661 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q3 2026.
Based on Caption Management's 13F filing for Q3 2026, filed 16 Nov 2026.